Literature DB >> 7880073

Expression of gonadotropin-releasing hormone receptor in human epithelial ovarian carcinoma.

A Imai1, T Ohno, K Ohsuye, T Tamaya.   

Abstract

We have previously demonstrated the presence of gonadotropin-releasing hormone (Gn-RH) messenger ribonucleic acid (mRNA) in epithelial ovarian carcinoma. In this study, the expression of Gn-RH receptor (Gn-RHR) was investigated in human ovarian carcinoma and human ovarian carcinoma cell line. Gn-RHR was determined by [3H]Gn-RH binding assay. Gn-RHR mRNA was determined by reverse transcription-polymerase chain reaction using oligonucleotide primers synthesized based on published human Gn-RHR sequence. Specific Gn-RH binding sites were shown to be present in plasma membrane isolated from five ovarian mucinous cystadenocarcinoma samples and one serous cystadenocarcinoma (Kd = 15.3 +/- 8.08 nmol/L). Gn-RHR mRNA was detected in four mucinous cystadenocarcinoma specimens, one serous cystadenocarcinoma, and SK-OV-3 cells, but not in white blood cells. These results suggest that Gn-RH may play an autocrine regulatory role in the growth of ovarian carcinoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7880073     DOI: 10.1177/000456329403100604

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  3 in total

Review 1.  Highlights of articles published in annals of nuclear medicine 2016.

Authors:  Hossein Jadvar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-28       Impact factor: 9.236

2.  NAV3, a Tumor Suppressor Gene, Is Decreased in Uterine Leiomyoma Tissue and Cells.

Authors:  Jasmine M Aly; Terrence D Lewis; Toral Parikh; Joy Britten; Minnie Malik; William H Catherino
Journal:  Reprod Sci       Date:  2020-01-01       Impact factor: 3.060

Review 3.  The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis.

Authors:  Carsten Gründker; Günter Emons
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-04       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.